ReviewMolecular neurobiology2026
Integrated Necroptosis Within Programmed Cell Death in Traumatic Brain Injury.
Review in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic brain injury (TBI), a major global public health burden, is characterized by complex pathophysiology involving primary and secondary injuries, with programmed cell death (PCD) pathways significantly impacting neuronal damage and neurological dysfunction. Substantial evidence over time highlights necroptosis-a caspase-independent, inflammatory form of PCD mediated by RIPK1/RIPK3/MLKL-as a key driver of secondary injury after TBI. However, the dynamic interplay between necroptosis and other PCD pathways after TBI remains poorly understood. In this review, we systematically describe the mechanisms involving necroptosis in TBI and its potential therapeutic targets, while delving into the interplay and regulatory relationships between necroptosis and other PCD pathways, including apoptosis, autophagy, pyroptosis, and ferroptosis. Future investigations and the formulation of therapeutic approaches for TBI should comprehensively consider the complex characteristics of necroptosis and its interplay with other pathways.
Indexed as
Identifiers
42461320What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.